Collaboration to cost-efficiently advance Mikra’s Mind-First Movement and customer acquisition strategy through direct contact with athletes seeking to elevate mental clarity, focus on enduranceTORONTO, July 31, 2025 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSX.V: LFST; OTCQB: LFSWF; FRANKFURT: M5B0) announced a strategic partnership signed May 26, 2025 between its wholly owned subsidiary Mikra Cellular Sciences and two leading fitness platforms: the globally recognized ASICS ...

Core Insights - MariMed Inc. has entered a strategic agreement with TILT Holdings to expand the distribution of its medical marijuana products to Pennsylvania [1][2] - Under a Management Services Agreement, MariMed will manage TILT's Standard Farms cultivation and processing facility in Pennsylvania starting September 1, 2025 [2][3] - MariMed will receive a management fee of 12.5% of Standard Farms' gross revenue for its management services [3] Company Overview - MariMed Inc. is recognized as a leading multi-state cannabis operator, known for its award-winning cannabis brands such as Betty's Eddies™, Bubby's Baked™, and Nature's Heritage™ [5] - The company aims to become a leading consumer packaged goods company in the medical marijuana sector through its "Expand the Brand" strategy [4] - TILT Holdings supports cannabis businesses with a diverse portfolio, including technology and cultivation services, and operates in multiple regions including North America and Europe [6] Market Context - Pennsylvania is identified as a strong medical marijuana market and is expected to transition into an adult-use market, presenting growth opportunities for MariMed [4] - The partnership with TILT is seen as a strategic move to leverage existing quality and trust established under the Standard Farms brand to enhance MariMed's market presence [4]

VANCOUVER, British Columbia, July 31, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), Enterprise SaaS, and Quantum Computing solutions, today announces its drone subsidiary ZenaDrone has initiated upgrading its membership to the Advocacy level with the influential   Association for Uncrewed Vehicle Systems International (AUVSI), enabling it to jo ...

PHILADELPHIA and VANCOUVER, British Columbia, July 31, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, announces the addition of UCLA Health Jonsson Comprehensive Cancer Center, a leading cancer center in California, to its ongoing pivotal Phase 3 clinical study (Bria-ABC, NCT06072612) evaluating Bria-IMT™ in combination with a checkpoi ...

CNSide available for the state of Texas in August 2025 Initial commercial focus on NCI-Designated Cancer Centers and large private healthcare systems Company will expand testing services and broaden regional availability over the next 12 months HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, announces th ...

CINCINNATI, July 31, 2025 (GLOBE NEWSWIRE) -- Hillman Solutions Corp. (Nasdaq: HLMN) (the “Company” or “Hillman”), a leading provider of hardware products and merchandising solutions, published its annual Corporate Responsibility fact sheet which highlights the Company’s ESG initiatives during the twelve months ending December 31, 2024. Hillman is proud to continue its commitment to long-term sustainability, sound corporate governance, and intentional social impact. These strategic priorities are ingrained ...

Group 1 - Flow Capital Corp. announced a C$15.0 million senior secured note investment in Common Wealth Pension Services Inc., with an initial advance of C$4.0 million [1] - Common Wealth provides a full-stack platform for group retirement plan administration, aimed at enhancing financial security for members and offering competitive retirement benefits for employers [2][4] - The investment from Flow Capital will facilitate Common Wealth in accelerating product innovation, expanding its customer base, and scaling operations to enhance retirement security accessibility in Canada [3] Group 2 - Common Wealth currently serves over 1,100 employers across Canada, with significant adoption among small and medium-sized businesses (SMBs) and their advisors [4] - The company aims to provide a "retirement plan for life" that extends beyond the workplace, and has received the global Innovation Award for Best Technology from Pensions & Investments [4] - Flow Capital focuses on providing flexible growth capital and alternative debt solutions to high-growth companies, helping them achieve growth without the dilutive impact of equity financing [6]

Company Increases Full-Year 2025 GuidanceMIAMI, July 31, 2025 (GLOBE NEWSWIRE) -- Laureate Education, Inc. (NASDAQ: LAUR), which operates five higher education institutions across Mexico and Peru, today announced financial results for the second quarter and six months ended June 30, 2025. Second Quarter 2025 Highlights (compared to second quarter 2024): On a reported basis, revenue increased 5% to $524.2 million. On an organic constant currency basis1, revenue increased 10% and was favorably affected by app ...

NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”) is pleased to announce that its strategic partner, PsyLabs – a leader in the production of purified psychedelic compounds – has successfully produced a GMP-aligned Ibogaine Total Alkaloid extract. The high-purity extract met all microbial safety standards for food-grade consumption, as verified by an accredited third-party laboratory. In 2024, Psyence BioMed acquired an equity stake in PsyLa ...

SAN DIEGO, July 31, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced it will report second quarter 2025 financial results after the close of U.S. financial markets on Thursday, August 7, 2025. Kura’s management will host a webcast and conference call at 4:30 p.m. ET / 1:30 p.m. PT to discuss the financial results and provide a corporate update. The liv ...